Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Research Report 2023

Publication ID:

PB502232826

Publication Date:

February 27, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global In Vitro Diagnostics (IVD) Quality Control Product market was valued at US$ 815.3 million in 2022 and is anticipated to reach US$ 918.2 million by 2029, witnessing a CAGR of 2.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for In Vitro Diagnostics (IVD) Quality Control Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for In Vitro Diagnostics (IVD) Quality Control Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for In Vitro Diagnostics (IVD) Quality Control Product in Clinical Chemistry is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of In Vitro Diagnostics (IVD) Quality Control Product include Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Technopath Clinical Diagnostics and Sun Diagnostics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Quality Control Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD) Quality Control Product.
The In Vitro Diagnostics (IVD) Quality Control Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Diagnostics (IVD) Quality Control Product market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostics (IVD) Quality Control Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Randox Laboratories
Roche Diagnostics
Abbott Diagnostics
Helena Laboratories
Seracare Life Sciences
Technopath Clinical Diagnostics
Sun Diagnostics
Zeptometrix Corporation
ISOLAB
Sysmex Corporation
Fortress Diagnostics
Meril Life Sciences
Multiplicom
Future Diagnostics Solutions
Surmodics
Segment by Type
Quality Control Products
Quality Assurance Services
Data Management Solutions
Segment by Application
Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) Quality Control Product companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Quality Control Products
1.2.3 Quality Assurance Services
1.2.4 Data Management Solutions
1.3 麻豆原创 by Application
1.3.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Chemistry
1.3.3 Immunochemistry
1.3.4 Hematology
1.3.5 Molecular Diagnostics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Perspective (2018-2029)
2.2 In Vitro Diagnostics (IVD) Quality Control Product Growth Trends by Region
2.2.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Dynamics
2.3.1 In Vitro Diagnostics (IVD) Quality Control Product Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Drivers
2.3.3 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Challenges
2.3.4 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) Quality Control Product Players by Revenue
3.1.1 Global Top In Vitro Diagnostics (IVD) Quality Control Product Players by Revenue (2018-2023)
3.1.2 Global In Vitro Diagnostics (IVD) Quality Control Product Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) Quality Control Product Revenue
3.4 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Quality Control Product Revenue in 2022
3.5 In Vitro Diagnostics (IVD) Quality Control Product Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Quality Control Product Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Type (2024-2029)
5 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2018-2029)
6.2 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2018-2023)
6.4 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2018-2029)
7.2 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2018-2023)
7.4 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2018-2029)
9.2 Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2018-2023)
9.4 Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.1.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.2.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Randox Laboratories
11.3.1 Randox Laboratories Company Detail
11.3.2 Randox Laboratories Business Overview
11.3.3 Randox Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.3.4 Randox Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.3.5 Randox Laboratories Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.4.4 Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Abbott Diagnostics
11.5.1 Abbott Diagnostics Company Detail
11.5.2 Abbott Diagnostics Business Overview
11.5.3 Abbott Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.5.4 Abbott Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.5.5 Abbott Diagnostics Recent Development
11.6 Helena Laboratories
11.6.1 Helena Laboratories Company Detail
11.6.2 Helena Laboratories Business Overview
11.6.3 Helena Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.6.4 Helena Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.6.5 Helena Laboratories Recent Development
11.7 Seracare Life Sciences
11.7.1 Seracare Life Sciences Company Detail
11.7.2 Seracare Life Sciences Business Overview
11.7.3 Seracare Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.7.4 Seracare Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.7.5 Seracare Life Sciences Recent Development
11.8 Technopath Clinical Diagnostics
11.8.1 Technopath Clinical Diagnostics Company Detail
11.8.2 Technopath Clinical Diagnostics Business Overview
11.8.3 Technopath Clinical Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.8.4 Technopath Clinical Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.8.5 Technopath Clinical Diagnostics Recent Development
11.9 Sun Diagnostics
11.9.1 Sun Diagnostics Company Detail
11.9.2 Sun Diagnostics Business Overview
11.9.3 Sun Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.9.4 Sun Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.9.5 Sun Diagnostics Recent Development
11.10 Zeptometrix Corporation
11.10.1 Zeptometrix Corporation Company Detail
11.10.2 Zeptometrix Corporation Business Overview
11.10.3 Zeptometrix Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.10.4 Zeptometrix Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.10.5 Zeptometrix Corporation Recent Development
11.11 ISOLAB
11.11.1 ISOLAB Company Detail
11.11.2 ISOLAB Business Overview
11.11.3 ISOLAB In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.11.4 ISOLAB Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.11.5 ISOLAB Recent Development
11.12 Sysmex Corporation
11.12.1 Sysmex Corporation Company Detail
11.12.2 Sysmex Corporation Business Overview
11.12.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.12.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.12.5 Sysmex Corporation Recent Development
11.13 Fortress Diagnostics
11.13.1 Fortress Diagnostics Company Detail
11.13.2 Fortress Diagnostics Business Overview
11.13.3 Fortress Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.13.4 Fortress Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.13.5 Fortress Diagnostics Recent Development
11.14 Meril Life Sciences
11.14.1 Meril Life Sciences Company Detail
11.14.2 Meril Life Sciences Business Overview
11.14.3 Meril Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.14.4 Meril Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.14.5 Meril Life Sciences Recent Development
11.15 Multiplicom
11.15.1 Multiplicom Company Detail
11.15.2 Multiplicom Business Overview
11.15.3 Multiplicom In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.15.4 Multiplicom Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.15.5 Multiplicom Recent Development
11.16 Future Diagnostics Solutions
11.16.1 Future Diagnostics Solutions Company Detail
11.16.2 Future Diagnostics Solutions Business Overview
11.16.3 Future Diagnostics Solutions In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.16.4 Future Diagnostics Solutions Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.16.5 Future Diagnostics Solutions Recent Development
11.17 Surmodics
11.17.1 Surmodics Company Detail
11.17.2 Surmodics Business Overview
11.17.3 Surmodics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.17.4 Surmodics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2018-2023)
11.17.5 Surmodics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bio-Rad Laboratories
Thermo Fisher Scientific
Randox Laboratories
Roche Diagnostics
Abbott Diagnostics
Helena Laboratories
Seracare Life Sciences
Technopath Clinical Diagnostics
Sun Diagnostics
Zeptometrix Corporation
ISOLAB
Sysmex Corporation
Fortress Diagnostics
Meril Life Sciences
Multiplicom
Future Diagnostics Solutions
Surmodics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.